May 2024
1. XU M, Gu M, Zhou J, Da J, et al
   [Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression.
   Int J Oncol. 2024;64:50.
   

   >> Share

   
   December 2023
2. WANG Z, Li L, Chu C, Wei X, et al
   CUDC?101 is a potential target inhibitor for the EGFR?overexpression bladder cancer cells.
   Int J Oncol. 2023;63:131.
   

   >> Share

   
   July 2023
3. LI Z, Jiang Y, Liu J, Fu H, et al
   Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway.
   Int J Oncol. 2023;63:84.
   

   >> Share

   
   June 2023
4. ZHANG S, Zhang C, Liu W, Zheng W, et al
   [Retracted] MicroRNA‑24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
   Int J Oncol. 2023;62:67.
   

   >> Share

   
   May 2023
5. HWANG TI, Cuiu YC, Chen YC, Chen PC, et al
   Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer.
   Int J Oncol. 2023;62:66.
   

   >> Share

   
   July 2021
6. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
   Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/betacatenin/Ncadherin axis.
   Int J Oncol. 2021;59.
   

   >> Share

   
   
7. PIAO XM, Hwang B, Jeong P, Byun YJ, et al
   Collagen type VIalpha1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
   Int J Oncol. 2021;59.
   

   >> Share

   
   December 2020
8. BIAN J, Li B, Zeng X, Hu H, et al
   [Corrigendum] Mutation of TGFbeta receptor II facilitates human bladder cancer progression through altered TGFbeta1 signaling pathway.
   Int J Oncol. 2020 Dec 14. doi: 10.3892/ijo.2020.5161.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share